** Vitrafy Life Sciences VFY.AX trading flat at A$1.6
** Bell Potter raises PT by 10 Au cents to A$2.10; retains "speculative buy"
** Expects higher cash flows on visibility of commercial launch timing of its VCU2 cryopreservation device in FY26
** Views recent leadership changes positively
** Ord Minnett assigns "speculative buy", with PT of A$2.30, per data compiled by LSEG
(Reporting by Nichiket Sunil in Bengaluru)
((Nichiket.Sunil@thomsonreuters.com))
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。